Xuelun Wu

Liraglutide, a glucagon-like peptide-1 receptor agonist, facilitates osteogenic proliferation and differentiation in MC3T3-E1 cells through phosphoinositide 3-kinase (PI3K)/protein kinase B (AKT), extracellular signal-related kinase (ERK)1/2, and cAMP/protein kinase A (PKA) signaling pathways involving β-catenin

Xuelun Wu, Shilun Li, Peng Xue et al. · Experimental Cell Research · 2017 · 76 citations

Mc3t3-e1 Cells, Extracellular Signal-related Kinase, Signal Transduction +11

IGF1 promotes osteogenic differentiation of mesenchymal stem cells derived from rat bone marrow by increasing TAZ expression

Peng Xue, Xuelun Wu, Lixin Zhou et al. · Biochemical and Biophysical Research Communications · 2013 · 65 citations

Regenerative Medicine, Mesenchymal Stem Cells, Taz Expression +11

Associations between fat distribution and volumetric bone mineral density in Chinese adults

Wei Zhang, Xiaohui Ma, Peng Xue et al. · Endocrine · 2014 · 49 citations

Obesity, Nutrition, Bone Health +8

Liraglutide Inhibits the Apoptosis of MC3T3-E1 Cells Induced by Serum Deprivation through cAMP/PKA/β-Catenin and PI3K/AKT/GSK3β Signaling Pathways.

Xuelun Wu, Shilun Li, Peng Xue et al. · PubMed · 2018 · 37 citations · Full text

Sclerostin, Apoptosis, Immunology +19

Role of sclerostin and dkk1 in bone remodeling in type 2 diabetic patients

Na Wang, Peng Xue, Xuelun Wu et al. · Endocrine Research · 2017 · 34 citations